ClinVar Miner

Submissions for variant NM_000527.5(LDLR):c.865T>C (p.Cys289Arg)

dbSNP: rs879254697
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
LDLR-LOVD, British Heart Foundation RCV000237446 SCV000295019 likely pathogenic Hypercholesterolemia, familial, 1 2016-03-25 criteria provided, single submitter literature only
Iberoamerican FH Network RCV000237446 SCV000748042 uncertain significance Hypercholesterolemia, familial, 1 2016-03-01 criteria provided, single submitter research
Ambry Genetics RCV002446474 SCV002683334 likely pathogenic Cardiovascular phenotype 2020-06-23 criteria provided, single submitter clinical testing The p.C289R variant (also known as c.865T>C), located in coding exon 6 of the LDLR gene, results from a T to C substitution at nucleotide position 865. The cysteine at codon 289, located in LDLR class A repeat 7, is replaced by arginine, an amino acid with highly dissimilar properties. Pathogenic LDLR mutations that result in the substitution or generation of cysteine residues within the cysteine-rich LDLR class A repeats and EGF-like domains are common in familial hypercholesterolemia (FH) (Villéger L. Hum Mutat. 2002;20(2):81-7). This particular cysteine alteration (also referred to as C268R) has been detected in an individual from an FH cohort; however, clinical details were limited (Robles-Osorio L et al. Arch. Med. Res., 2006 Jan;37:102-8). Internal structural analysis indicates this alteration eliminates a disulfide bond critical for the structural integrity of LDLR class A repeat 7 (Ambry internal data). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.